Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000871953 | SCV001013696 | likely benign | Marfan syndrome; Familial thoracic aortic aneurysm and aortic dissection | 2024-06-21 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV001175846 | SCV001339622 | likely benign | Familial thoracic aortic aneurysm and aortic dissection | 2019-01-27 | criteria provided, single submitter | clinical testing | |
Institute of Human Genetics, |
RCV002287450 | SCV002577977 | likely benign | Marfan syndrome | 2022-05-03 | criteria provided, single submitter | clinical testing | ACMG categories: BP4,BP6,BP7 |
Ambry Genetics | RCV001175846 | SCV004078975 | likely benign | Familial thoracic aortic aneurysm and aortic dissection | 2023-09-05 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
All of Us Research Program, |
RCV002287450 | SCV004823064 | likely benign | Marfan syndrome | 2023-12-13 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV005231925 | SCV005879486 | likely benign | not provided | 2024-08-21 | criteria provided, single submitter | clinical testing |